This peer-reviewed publication marks an important milestone following initial release of study information in August 2024 (see "Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT"). The ...
This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...
Researchers at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two receptors ...
The FDA has introduced a new “plausible mechanism pathway” aimed at expediting approval of personalized therapies for rare diseases. The approach, detailed in a Nov. 12 article in The New England ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. White House says admiral ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. 4 law enforcement officers ...
COULD HELP OTHERS. TERRY BECKER IS A RETIRED FIFTH GRADE TEACHER, BUT THE YOUNG PEOPLE GETTING HIS ATTENTION THESE DAYS ARE HIS FOUR GRANDDAUGHTERS. OUR DAUGHTER AND HER HUSBAND, AND TWO GIRLS. THEY ...
ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback